Patient Diversity Addressed in New Hepatitis C Study

A landmark clinical trial is underway, to study the effectiveness of three hepatitis C medications. The initial patient at University of Florida Health has begun a 12-week drug regimen and is one of 3,750 people who will be randomly assigned one of the medications as part of the five-year trial, said David R Nelson, MD, [...]